Bactericidal activity of daptomycin against vancomycin-resistantEnterococcus faecium in an in vitro pharmacokinetic model
Explore this paper's citation graph
Summary
Results suggest that in the clinical setting, daptomycin dosages of approximately 6 mg/kg are required to achieve bactericidal activity against vancomycin-resistantEnterococcus faecium.
- Type
- article
- Published
- 1991-12-01
- Cited by
- 10
- References
- 22
- OpenAlex
- https://openalex.org/W1666362
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:19822637
Keywords
Political science, Humanities, Art
References
- In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance
- Suboptimal effect of daptomycin in the treatment of bacteremias.
- In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic
- The enterococcus: "putting the bug in our ears".
- High-level vancomycin-resistant enterococci causing hospital infections
- Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032
- Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model
- In-vitro activity of LY 146032, a novel cyclic lipopeptide, alone and in combination with gentamicin or tobramycin against enterococci.
- Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.
- New In Vitro Model to Study the Effect of Antibiotic Concentration and Rate of Elimination on Antibacterial Activity
- Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
- Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.
- Antibiotic resistance in enterococci.
- Daptomycin (LY146032) treatment of experimental enterococcal endocarditis
- Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin-resistant Enterococcus faecium.
- Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci
- Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.
Cited by
- The protein-binding and drug release properties of macromolecular conjugates containing daptomycin and dextran.
- In Vitro Activity of Daptomycin against Vancomycin-Resistant Enterococci of Various Van Types and Comparison of Susceptibility Testing Methods
- Killing kinetics of cefuroxime againstStreptococcus pneumoniae in an in vitro model simulating serum concentration profiles after intramuscular administration
- Daptomycin: A cyclic lipopeptide antimicrobial agent
- Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections
- Daptomycin – a novel antibiotic against Gram-positive pathogens
- IDENTIFICATION, CHARACTERIZATION AND ANTIMICROBIAL SUSCEPTIBILITY TESTING OF ENTEROCOCCUS SPECIES ISOLATED FROM VARIOUS CLINICAL SPECIMENS
- Daptomycin: the first approved lipopeptide antimicrobial.
- Rapid and quantitative detection of COVID-19 markers in micro-liter sized samples
- Daptomycin
Related papers
No related papers recorded.